As its Drug Business Sees Growth in 2019, Lonza Continues to Search for New CEO

Swiss pharma and chemical company Lonza continues to hunt for a new chief executive officer following the abrupt departure of Marc Funk, who resigned from his position eight months after taking over for Richard Ridinger, who helmed the company for seven years.